Abstract
The quality of liposomes is highly dependent on their starting materials. The characteristics of liposomal formulations, including particle size, entrapment efficiency, polydispersity index, morphology, zeta potential, stability, release of drugs from liposomes, etc., is crucial for their therapeutic efficacy. Techniques and methods to measure the characteristics of liposomal formulations have their own pros and cons, and thus on basis of the properties of liposomal formulation, a suitable method for measurement should be adopted. In addition to their in vitro characterization, in vivo studies are essential to evaluate their biological behaviors, such as pharmacology, pharmacokinetics, therapeutic efficacy, safety, and toxicity study, which provides detailed information about the quality of liposomes.
References
Abolfazl A, Rogaie RS, Soodabeh D, Sang WJ, Nosratollah Z, Younes H, Mohammad S, Mohammad K, Kazem NK (2013) Liposome: classification, preparation, and applications. Nanoscale Res Lett 8(1):102–110
Arouri A, Mouritsen OG (2013) Membrane-perturbing effect of fatty acids and lysolipids. Prog Lipid Res 52(1):130–140
Bahari LAS, Hamishehkar H (2016) The impact of variables on particle size of solid lipid nanoparticles and nanostructured lipid carriers; a comparative literature review. Adv Pharm Bull 6(2):143–151
Bera B (2015) Nanoporous silicon prepared by vapour phase strain etch and sacrificial technique. In: Proceedings of the international conference on Microelectronic Circuit and System (Micro), Kolkata, pp 42–45
Burgess DJ, Hussain AS, Ingallinera TS, Chen ML (2002) Assuring quality and performance of sustained and controlled release parenterals: workshop report. AAPS PharmSci 4(2):13–23
Committee for Human Medicinal Products. Reflection paper on the data requirements for intravenous liposomal products developed with reference to an innovator liposomal. European Medicines Agency. https://www.ema.europa.eu/documents/scientific-guideline/reflection-paper-data-requirements-intravenous-liposomal-products-developed-reference-innovator_en-0.pdf
Danaei M, Dehghankhold M, Ataei S, Davarani FH, Javanmard R, Dokhani A, Khorasani S, Mozafari MR (2018) Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems. Pharmaceutics 10(2):57–73
Gabizon AA, Barenholz Y, Bialer M (1993) Prolongation of the circulation time of doxorubicin encapsulated in liposomes containing a polyethylene glycol-derivatized phospholipid: pharmacokinetic studies in rodents and dogs. Pharm Res 10(5):703–708
Guidance for Industry. Liposome drug products, chemistry, manufacturing, and controls; human pharmacokinetics and bioavailability; and labeling documentation. U.S. Food and Drug Administration. http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm070570.pdf. Accessed Apr 2018
Jiang G, Su JF, Fu H, Xing JX, Dong YX, Wu CB (2012) Content determination of lysophosphatidylcholine in seal oil based lipid emulsion for parenteral nutrition by HPLC-ELSD. Chin J Mod Appl Pharm 29(5):440–444
Jin YG, Du LN, Chen Y, Ling PX (2015) Application of nanotechnology in drug delivery, 1st edn, pp 174–179
Kapoor M, Lee SL, Tyner KM (2017) Liposomal drug product development and quality: current us experience and perspective. AAPS J 19(3):632–641
Kuntsche J, Horst JC, Bunjes H (2011) Cryogenic transmission electron microscopy (cryo-TEM) for studying the morphology of colloidal drug delivery systems. Int J Pharm 417(1–2):120–137
Li H, Gong W, Zhang H, Meng XG (2014) Determination of lysolipid in vinorelbine liposome for injection by HPLC-charged aerosol detector. Chin J New Drug 23(13):1493–1496
Lin PC, Lin S, Wang PC, Sridhar R (2014) Techniques for physicochemical characterization of nanomaterials. Biotechnol Adv 32(4):711–726
Manaia EB, Abuçafy MP, Chiariandréo BG, Silva BL, Oshiro-Júnior JA, Chiavacci LA (2017) Physicochemical characterization of drug nanocarriers. Int J Nanomedicine 12:4991–5011
Mills JK, Needham D (2005) Lysolipid incorporation in dipalmi toylphosphatidylcholine bilayer membranes enhances the ion permeability and drug release rates at the membrane phase transition. BBA-Biomenbranes 1716(2):77–96
Proffitt RT, Williams LE, Presant CA, Tin GW, Uliana JA, Gamble RC, Baldeschwieler JD (1983) Tumor-imaging potential of liposomes loaded with In-111-NTA: biodistribution in mice. J Nucl Med 24(1):45–51
Putri DCA, Dwiastuti R, Marchaban M, Nugroho AK (2017) Optimization of mixing temperature and sonication duration in liposome preparation. J Pharm Sci Community 14(2):79–85
Severs NJ (2007) Freeze-fracture electron microscopy. Nat Protoc 2(3):547–576
Solomon D, Gupta N, Mulla NS, Shukla S, Guerrero YA, Gupta V (2017) Role of in vitro release methods in liposomal formulation development: challenges and regulatory perspective. AAPS J 19(6):1669–1681
Tochilin VP, Weissing V (2002) Liposomes, 2nd edn, Oxford University Press, New York, pp 45–46, 149–164
Yang ZZ, Gao W, Liu YJ, Pang N, Qi XR (2017) Delivering siRNA and chemotherapeutic molecules across BBB and BTB for intracranial glioblastoma therapy. Mol Pharm 14(4):1012–1022
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Singapore Pte Ltd.
About this entry
Cite this entry
Lin, M., Wang, R., Qi, XR. (2021). Quality Evaluation of Drug-Loaded Liposomes. In: Lu, WL., Qi, XR. (eds) Liposome-Based Drug Delivery Systems. Biomaterial Engineering. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-49320-5_25
Download citation
DOI: https://doi.org/10.1007/978-3-662-49320-5_25
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-49318-2
Online ISBN: 978-3-662-49320-5
eBook Packages: Chemistry and Materials ScienceReference Module Physical and Materials ScienceReference Module Chemistry, Materials and Physics